Seed

Seed is a company focused on microbial sciences, aiming to enhance human and planetary health through innovative applications of microbes. Their flagship product, the DS-01® Daily Synbiotic, is designed to support gut health by combining probiotics and prebiotics. This synbiotic formulation is intended to improve digestive health, support the immune system, and promote overall well-being.

The DS-01® Daily Synbiotic is based on scientific research and is developed to ensure the delivery of beneficial bacteria to the gut. This product is part of Seed's broader commitment to advancing the understanding and application of microbiome science. By focusing on the gut microbiome, Seed aims to provide a foundation for improved health outcomes through the modulation of microbial communities within the body.

The evidence provided supports that Seed’s DS-01 Daily Synbiotic has been studied in clinical and randomized trials and may improve some microbiome-related measures and digestive outcomes. The supplied sources also support quality-testing and a science-first positioning. Broad claims about whole-body health are less directly supported than gut- and microbiome-related outcomes.